Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed May 14, 2024 · 10-Q · 44 days after period end · 0001520138-24-000204
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$8.07M | -$15.04M | -$7.04M | -$2.99M |
| EPS Diluted | -$0.20 | -$0.43 | -$0.28 | -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end
